John Peter Gutfreund
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Peter Gutfreund
John Peter Gutfreund was last confirmed as Board Member at Insight Molecular Diagnostics Inc. (IMDX) in a filing dated May 19, 2023. Insight Molecular Diagnostics Inc. reported in an 8-K filed August 1, 2022 that John Peter Gutfreund was appointed director, effective July 28, 2022.
“Effective July 28, 2022, the Board of Directors (the “Board”) of Oncocyte Corporation (“Oncocyte” or the “Company”) elected John Peter Gutfreund, age 36, to serve as a director on the Board, with a term that expires at the Annual Meeting of Shareholders of the Company to be held in 2023 or until his earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-01-01–2023-05-19
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.